How much does Ofatumumab cost?

Ofatumumab (Ofatumumab) is a drug used to treat adults with the relapsing form of multiple sclerosis, in which patients have periods of mild or no symptoms after an onset (relapse). It is used in patients with active disease, meaning they have signs of recurrence and/or active inflammation on scans. Ofatumumab is also available as an injection (Arzerra) and is used to treat chronic lymphocytic leukemia (a slowly developing cancer in which too many of a certain type of white blood cell accumulate in the body).

The active substance in ofatumumabOfatumumab is a monoclonal antibody (a protein) designed to recognize and attach to the specific target CD20 on the surface of B cells (a type of white blood cell). B cells play a key role in multiple sclerosis by attacking the protective sheath (sheath) surrounding nerves in the brain and spinal cord, causing inflammation and damage. By targeting B cells, ofatumumab helps reduce their activity, thereby relieving symptoms or slowing the progression of the disease. Ofatumumab's side effects are consistent with other similar drugs and are considered manageable.

The original drug of ofatumumab has been launched in China and has also been included in medical insurance. Only patients who meet the indications can be reimbursed. The price is around tens of thousands of yuan, and domestic purchase channels are relatively difficult. The European version of ofatumumab original drug specifications20mg/0.4mL each sold overseas may cost around RMB 16,000 (the price may fluctuate due to the exchange rate). It is expensive and there are currently no generics of ofatumumab. For more drug information and specific prices, please consult a medical consultant.